Nigel Ten Fleming
Chairperson
Pharmaceuticals
Tech-Observer
Spain
Biography
Nigel Ten Fleming has started and been involved with highly innovative healthcare companies in the biotechnology and pharmaceuticals sectors. In particular, solving strategic challenges for cuttting-edge science, and finding efficient ways to monetize it, and make a difference in healthcare. He had spent his career in startup companies.
Research Interest
Pharmaceuticals, biotechnology, diagnostics, Board of Directors, board strategies, strategic planning, fundraising, venture capital, angel investors, licensing deals, collaborative reseach agreements, partnerships, company sale, asset liquidation, medical science, gene technology, genetic testing, biosimilars, biobetters, biological drugs, repurposing, reformulating, patent strategy, new intellectual property, cutting edge science, medical innovations, patient care.
